Clinical Trial Update: Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney [Phase 2]

View source ↗

Summary

Phase 2 trial investigating focal ablative stereotactic radiosurgery for renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Renal Cell Carcinoma | Phase 2 | Status: UNKNOWN